Navigating The Journey Towards “Future-Proof” Clinical Data Assets
As the digital transformation of clinical research and the adoption of decentralized clinical trials continue to gain momentum, sponsors are increasingly using wearable motion-sensing technologies to capture real-world digital biomarker data. In exchange for the valuable insights into treatment efficacy and quality of life they provide, successful wearable technology deployments require a significant investment of time and resources from clinical trial sponsors, their partners, and the patients they serve. By leveraging a sensor platform that collects and provides access to “future-proof” raw source data, sponsors can generate reusable clinical data assets that maintain their value over time, even as sophisticated analytic techniques and novel algorithms emerge.